Volume 5, Issue 4, December 2019

Research and innovations as key drivers to end tuberculosis in the WHO European Region by 2030

Scaling up tuberculosis research in the WHO European Region

Interview with Sevim Ahmedov, Prevention and M&E Team Lead at the United States Agency for International Development (‎USAID)

Interview with Alena Skrahina, Deputy National TB Program Manager, Belarus

Interview with Safrali Naimov, Executive Director of Stop TB Partnership, Tajikistan

Interview with Dr Vivian Cox

Effectiveness and safety of bedaquiline-containing regimens among adults with multidrug- or extensively drug-resistant pulmonary TB in Belarus: a nationwide cohort study

Lost to follow-up in MDR-TB patients in Armenia in 2013–2018

Poor follow-up of paediatric tuberculosis contacts in Tbilisi, Georgia

A cross-sectional study of the turnaround time of Armenia’s National Tuberculosis Programme Laboratory Services in 2017–2018

Underreporting of diagnosed tuberculosis cases to the national surveillance system in Armenia in 2017

Risk factors associated with loss to follow-up among multidrug-resistant tuberculosis patients in the Republic of Moldova in 2014–2016

Compliance of drug-resistant tuberculosis treatment regimens with drug susceptibility testing results and its association with treatment outcomes in Georgia

Risk factors associated with RR/MDR-TB among new pulmonary tuberculosis patients in urban and rural areas of Ukraine in 2017: retrospective analysis of routine surveillance data

Diagnosis of tuberculosis among patients with unexplained pleural effusion in Belarus: role of surgical biopsy and Xpert MTB/RIF

Delays and associated risk factors, in the detection and treatment of rifampicin-resistant tuberculosis patients in Ukraine

Does low Mycobacterium tuberculosis concentration in the sample influence GeneXpert rifampicin susceptibility results in the Republic of Moldova?